Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-08-28

Clinical Trial Update: MyPrEP Plus: Development and Pilot Testing of Novel Preexposure Prophylaxis Decision Support Tools for Transgender Women [NA]

View source ↗

Summary

The MyPrEP Plus trial, which aimed to develop and pilot test decision-support tools for transgender women to aid HIV pre-exposure prophylaxis, has been terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Public Health Foundation Enterprises, Inc. | Conditions: HIV Pre-exposure Prophylaxis, HIV Prevention and Care | NA | Status: TERMINATED